Dallas, United States
Osteal Therapeutics is a clinical-stage pharmaceutical company founded in 2013. The company focuses on developing innovative musculoskeletal therapeutics aimed at treating orthopedic infections and their consequences. With the slogan "Revolutionizing the treatment of orthopedic infection. Preserving Limbs. Preserving Lives," Osteal Therapeutics is positioning itself as a pioneering force in the biotechnology, health care, medical devices, and pharmaceutical industries.
The company's most recent milestone was a significant $50.00M Series D investment completed on 05 June 2024. Notable investors in this round included Johnson & Johnson Development Corporation, Huimei Capital, Zimmer Biomet, and Gideon Strategic Partners, reflecting confidence from industry leaders in Osteal Therapeutics' potential to address critical unmet needs in orthopedic treatment. Headquartered in the United States, Osteal Therapeutics is poised to make a lasting impact on the healthcare landscape with its innovative approach to musculoskeletal therapeutics.
